• New genetic mechanism of protection against malaria discovered

New genetic mechanism of protection against malaria discovered

A study led by Prof. Francesco Cucca, has revealed a new genetic mechanism that protects against malaria.  Conducted by a team primarily consisting of researchers from the Institute for Genetic and Biomedical Research of the National Research Council (CNR-IRGB) and the University of Sassari, the study of Marini, Mingoia, Steri et al. entitled “Reduced cyclin D3 expression in erythroid cells protects against malaria” shows how a naturally occurring variant in the Sardinian population  causally affects the biology of red blood cells and disrupts the growth of the malaria parasite, opening up new avenues for future therapeutic strategies. The research focuses on the rs112233623-T genetic variant, which is located in an erythroid enhancer that controls the expression of the CCND3 gene in red blood cell precursors. CCND3 encodes Cyclin-D3, which activates cell division and enhances the pentose-phosphate pathway (PPP), thereby counteracting reactive oxygen species (ROS). Previous genome-wide association analyses of approximately 7,000 volunteers from the SardiNIA general population cohort study in the Lanusei valley in Sardinia have shown that the rs112233623-T variant is associated with higher levels of haemoglobin A2, increased erythrocyte size, and reduced erythrocyte number. The study shows that rs112233623-T, by disrupting a SMAD3 transcription factor binding site, weakens enhancer activity, resulting in reduced CCND3 expression. This lowers cyclin-D3 levels, thereby slowing the transition from the G1 to S phase of the cell cycle during erythropoiesis, which is consistent with the observed decrease in the number of larger erythrocytes. The rs112233623-T variant is only present in Europe, suggesting that it originated after the out-of-Africa migration of modern humans, and within Europe, it shows a south-to-north gradient, with the highest frequency found in Sardinia. Using population genetic methods, the study further revealed consistent signatures of positive selection for this variant in Sardinia, accounting for its high frequency on this island.   Given the critical role of cyclin-D3 in red blood cell precursors, the authors hypothesised that past endemic malaria in Sardinia was the main driver of such positive selection. Through functional experimentation, the authors then demonstrated that Plasmodium falciparum grows less efficiently in red blood [...]

Genetic study links gut motility to vitamin B1

A new collaborative international genetic study led by Prof. Mauro D’Amato from the CIC bioGUNE in Spain and LUM University in Italy, with contributions from the research group of Dr. Serena Sanna at CNR‑IRGB, has identified genetic factors that influence bowel movement frequency. The study was  Published in Gut, [...]

Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure

Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure In this study, the authors sought to assess tolerability and efficacy of an inhalable lung-to-heart nano-in-micro technology (LungToHeartNIM) for cardiac-specific targeting of a mimetic peptide (MP), a first-in-class for modulating impaired L-type calcium channel (LTCC) [...]

Double recognition for Serena Sanna, Head of Research

07/11/2023 Double recognition for Serena Sanna, Research Director at the Institute for Genetic and Biomedical Research (Cnr-Irgb) in Cagliari: on Monday, November 13 in Rome, at the Protomoteca Hall of the Capitoline Hill, she receives the “Marcello Sgarlata Research Award”. The prize is granted, upon nomination by the President [...]

Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype

In this study, we evaluated the predictive and prognostic role of HER2 protein/gene expression levels in combination with clinicopathologic features in patients who received neoadjuvant trastuzumab-based chemotherapy. The tumor pathologic complete response (pCR) rate was 40.9%, and the mortality rate was lower than in subjects with a lower response. [...]

ERC Starting Grant 2022 awarded to Serena Sanna at the IRGB

"SEMICYCLE" the project conceived by Serena Sanna, of the Institute of genetic and biomedical research (Irgb) of the National Research Council of Cagliari, was funded under the Starting Grants 2022 program of the European Research Council (ERC) for a total of 1.5 million euros. The project is aimed at [...]

The hidden gene-microbes communication

In a new study, a group of researchers from the University of Groningen who have joined forces as the Groningen Microbiome Team have shown that your genes influence the composition of your gut microbiome. Dr. Serena Sanna, now Director of Research at the IRGB-CNR Institute has coordinated this study together with [...]